Journal of Microbiology Research
p-ISSN: 2166-5885 e-ISSN: 2166-5931
2012; 2(6): 152-156
doi: 10.5923/j.microbiology.20120206.01
Khaled M. Hassanein 1, Marwa Salah Mostafa 1, Raafat El- Sanhoty 2, K. M. Hassan 3
1Department of Medical Microbiology & Immunology, College of medicine, Qassim University, Buraidah, Saudi Arabia
2Department of Food Science and Human Nutrition,, College of Agriculture, Qassim University, Buraidah, Saudi Arabia
3Department of Medical Laboratories, King Fahad Specialized Hospital,Buraidah, Saudi Arabia
Correspondence to: Marwa Salah Mostafa , Department of Medical Microbiology & Immunology, College of medicine, Qassim University, Buraidah, Saudi Arabia.
Email: |
Copyright © 2012 Scientific & Academic Publishing. All Rights Reserved.
Health care-associated bacteremia cause important morbidity and mortality and have a considerable impact on healthcare costs. Infections caused by extended spectrum beta-lactamase producing bacteria are of clinical and epidemiological importance, since their mobile genetic elements facilitate cross-infection. Objectives: To analyze health care-associated bacteremia in ICUs of King Fahad Specialized Hospital and to assess ESBL production in the isolated Gram negative bacteria. Methods: This study included 519 patients. Their blood samples were collected for blood culture. The isolates were identified and antibiotic sensitivity tests were performed. The type of B-lactamase gene was determined by polymerase chain reaction (PCR). Results: The rate of health care-associated bacteremia was 9.8%. Gram positive organisms were detected in 67.8 %; methithilin resistant Staph.aureus (MRSA) was the most prevalent (17.8 %). Gram negative bacilli were detected in 30.6 %. E.coli was the most common (12.9%). The production of extended spectrum β-lactamase (ESBL) enzyme was positive in 84.2% of the isolated Gram negative isolates. Temoniera (TEM) was the main type of β-lactamase. Conclusion: The isolation of multi-drug resistant bacteria and ESBL producing Gram negative organisms in ICU patients resulted in a greater awareness of implementation of new rules for microbiological screening and infection control measures.
Keywords: Health Care-Associated Bacteremia, Klebsiella Pneumoniae, Methicillin Resistant Staph Aureus, Extended Spectrum Beta-lactamase
Cite this paper: Khaled M. Hassanein , Marwa Salah Mostafa , Raafat El- Sanhoty , K. M. Hassan , "Multi-Drug Resistance in Health Care-Associated Bacteremia in Intensive Care Units at King Fahad Specialized Hospital, Buraidah, Saudi Arabia", Journal of Microbiology Research, Vol. 2 No. 6, 2012, pp. 152-156. doi: 10.5923/j.microbiology.20120206.01.
|
|
|
|
|
[1] | F.S. Erdinc, M.A. Yetkin, C. Ataman Hatipoglu, M. Yucel, A.E. Karakoc, M.A. Cevik, N. Tulek, ”Five-year surveillance of nosocomial infections in Ankara Training and Research Hospital”, Elsevier, Journal of Hospital Infection, vol.64, pp.391-396, 2006. |
[2] | Vesna Šuljagić, Miloje Čobeljić, Slavenka Janković, Veljko Mirović, Ljiljana Marković-Denić,Predrag Romić, Dragan Mikić, “Nosocomial bloodstream infections in ICU and non-ICU patients”, Elsevier, American Journal of Infection Control, vol.33, pp.333-340, 2005. |
[3] | Jason W. Bennett, Clinton K. Murray, Robert L. Holmes, Jan E. Patterson, James H. Jorgensen,, “Diminished vancomycin & daptomycin susceptibility during prolonged bacteremia with MRSA”, Elsevier, Diagnostic Microbiology & Infectious Disease, vol.60, pp.437-440, 2008. |
[4] | Ahmed S. Al-Dhaheri, Mohamed S. Al-Niyadi, Ahmed D. Al-Dhaheri, Salim M. Bastaki, “Resistance patterns of bacterial isolates to antimicrobials from 3 hospitals in the UAE”, Saudi Medical Journal, vol.30, no.5, 618-623, 2009. |
[5] | Mark E. Rupp, Paul D Fey, Rupp ME, Fey PD, “Extended-spectrum β-lactamase (ESBL) - producing Enterobacteriaceae: Considerations for diagnosis, prevention and drug treatment”, Adis, Drugs, vol.63, pp.353–365, 2003. |
[6] | Johann DD Pitout, Kevin B Laupland, “Extended-spectrum â-lactamase-producing Enterobacteriaceae: an emerging public-health concern”, Elsevier, Lancet Infectious Diseases., vol.8, pp.159–166, 2008. |
[7] | Karen Bush, “Bench-to-bedside review: the role of â-lactamases in antibioticresistant gram-negative infections”, BioMed Central, Critical Care, vol.14, pp.224, 2010. |
[8] | Simor A.E, Ofner-Agostini M, Bryce E, Green K, McGeer A, Mulvey M, Paton S, “The evaluation of methicillin resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance”, Canadian Medical Association, Canadian Medical Association Journal, vol.165 no.1, pp.21-26, 2001. |
[9] | Akujobi C.N. and Ewuru Chika P., “Detection of extended spectrum β–lactamase in Gram negative bacilli from clinical specimens in a teaching hospital in South Eastern Nigeria”, Nigerian Medical Journal, vol.5, no.4, pp.141-146, 2010. |
[10] | National Committee for Clinical Laboratory Standards, “Performance Standards for Antimicrobial Susceptibility Testing; Thirteenth Informational Supplement”, NCCLS documents M100-S13, Wayne, Pennsylvania, USA, 2003. |
[11] | Tobias Kieser, “Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli”, Elsevier, Plasmid, vol.12, pp.19–36, 1984. |
[12] | Jesus Silva, Rodolfo Gstica, Cecilia Aguilar, Zita Becerra, Ulises Garza-Ramos, Manuel Velazquez, GuadalupeMiranda, Blanca Leanos, Fortino Solorzano, Gabriela Echaniz, “Outbreak of infection with extended-spectrum beta- lactamase producing Klebsiella pneumoniae in a Mexican hospital”, American Society for Microbiology, Journal of Clinical Microbiology, vol.39, no.9, pp.3193-3196, 2001. |
[13] | Johann D.D. Pitout, Ashfaque Hossain, Nancy D. Hanson, “Phenotypic and molecular detection of CTX-M-beta- lactamases produced by Escherichia coli and Klebsiella spp.”, American Society for Microbiology, Journal of Clinical Microbiology, vol.42, no.12, pp.5715-5721, 2004. |
[14] | Marcia Regina G. Vasques, Alexandre Ribeiro Bello, Cristiane da Cruz Lamas, Juarez Correa, Jose Augusto Adler Pereira, “β-lactamase producing enterobacteria isolated from surveillance swabs of patients in a cardiac intensive care unit in Rio de Janeiro, Brazil”, Elsevier, Brazilian Journal of Infectious Diseases., vol.15, no.1, pp.28-33, 2011. |
[15] | Wendy Sligl, Geoffrey Taylor, Peter G. Brindley, “Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes”, Esevier, International society for infectious diseases, vol.10, pp.320-325, 2006. |
[16] | Michael B. Edmond, Sarah E. Wallace, Donna K. McClish, Michael A. Pfaller, Ronald N. Jones, and Richard P. Wenzel, Edmond MB, Wallace SE, McClish D.K., Pfaller MA, Jones R and Wenzel RP, “Nosocomial bloodstream infections in United States hospitals: a 3-year analysis”, Infectious Diseases Society of America, Clinical Infectious Diseases, vol.29, pp.239–244, 1999. |
[17] | S. Nedjai, A. Barguigua, N. Djahmi, L. Jamali, K. Zerouali, M. Dekhil, M. Timinoun, “Prevalence and characterization of extended spectrum β-lactamases in Klebsiella- Enterobacter-Serratia group bacteria, in Algeria”, Elsevier, Médecine et maladies infectieuses, vol.42, pp.20–29, 2012. |
[18] | Hajime Kanamori, Rizalina B. Navarro, Hisakazu Yano, Lydia T. Sombrero, Ma. Rosario Z. Capeding, Socorro P. Lupisan, Remigio M. Olveda, Kazuaki Arai, Hiroyuki Kunishimad, Yoichi Hirakatac, Mitsuo Kaku, “Molecular characteristics of extended-spectrum â-lactamases in clinical isolates of Enterobacteriaceae from the Philippines”, Elsevier, Acta Tropica, vol.120 pp.140– 145, 2011. |
[19] | Yoichi Hirakata, Junichi Matsuda, Yoshitsugu Miyazaki, Shimeru Kamihira, Sayoko Kawakami, Yukihisa Miyazawa, Yasuo Ono, Nobuhiko Nakazaki, Yasuyoshi Hirata, Matsuhisa Inoue, John D. Turnidge, Jan M. Bell, Ronald N. Jones, Shigeru Kohno, “Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002)”, Elsevier, Diagnostic Microbiology & Infectious Disease, vol.52, pp.323–329, 2005. |
[20] | George A. Jacoby,Luisa Silvia Munoz-Price, “The new beta-lactamases”, New England Journal of Medicine, vol.352, no.4, pp.380-391, 2005. |